ABVC BioPharma Inc

ABVC

Company Profile

  • Business description

    ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

  • Contact

    44370 Old Warm Springs Boulevard
    FremontCA94538
    USA

    T: +1 510 668-0881

    E: [email protected]

    https://www.abvcpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    19

Stocks News & Analysis

stocks

Overvalued ASX mining giant

Solid start to 2026 but shares overvalued.
stocks

Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?

With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
stocks

Tesla earnings: Shares fall as market focuses on uncertainty in near term

Are shares overpriced despite the fall?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,321.6022.10-0.24%
CAC 408,225.7818.910.23%
DAX 4024,207.7956.660.23%
Dow JONES (US)46,734.61144.200.31%
FTSE 1009,578.5763.570.67%
HKSE26,141.43173.450.67%
NASDAQ22,941.80201.400.89%
Nikkei 22549,230.51588.901.21%
NZX 50 Index13,412.6735.570.27%
S&P 5006,738.4439.040.58%
S&P/ASX 2009,022.9021.30-0.24%
SSE Composite Index3,941.3918.980.48%

Market Movers